IBRX vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

IBRX

39.5
AI Score
VS
BBIO Wins

BBIO

57.2
AI Score

Investment Advisor Scores

IBRX

40score
Recommendation
SELL

BBIO

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBRX BBIO Winner
Revenue 95.45M 438.19M BBIO
Net Income -863.16M -322.45M BBIO
Net Margin -904.3% -73.6% BBIO
Operating Income -131.49M -213.03M IBRX
ROE 82.5% 12.8% IBRX
ROA -137.3% -26.5% BBIO
Total Assets 628.50M 1.22B BBIO
Cash 75.67M 677.91M BBIO
Current Ratio 5.72 1.23 IBRX
Free Cash Flow -147.15M -268.89M IBRX

Relative Price Performance (Last 90 Days)

IBRX 1M: +2.2% · 3M: +9.9% BBIO 1M: -13.6% · 3M: +7.2%

Current Technical Phase

IBRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.3% over 20 days), RSI 50

RSI (14): 50.4 · Price: $7.91

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 29.8 · Price: $72.44

Fundamentals Snapshot

Metric IBRX BBIO
Market Cap
Forward P/E -62.4 2634.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.9% 1.2%
Gross Margin 1.0% 0.9%
Operating Margin -1.2% -0.4%
EPS -0.91 -3.39
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.